We found 132 records for "Legal"

Articles

UK pharma disclosure of payments: lessons from the US Sunshine Act

22nd June 2015

 UK pharma disclosure of payments: lessons from the US Sunshine ActArticles

In the second article on pharma's disclosure of payments in the UK, Andrew McConaghie talks to the PMCPA's Heather Simmonds about potential complaints, and lessons from the US.The pharma industry...

Read more

Data, ethics and anonymisation in a changing digital communications world

19th May 2015

 Data, ethics and anonymisation in a changing digital communications worldArticles

This is the last in a series of three articles examining the legal and ethical dilemmas faced when using new mediums and data sources for healthcare market research and data...

Read more

A new era of transparency: UK pharma prepares to publish doctor payments

5th May 2015

 A new era of transparency: UK pharma prepares to publish doctor paymentsArticles

Pharma companies across Europe are gearing up to disclose for the first time the names of health professionals and healthcare organisations who they have made payments to. In the first...

Read more

Protecting the future: the regenerative medicine evolution

10th March 2015

 Protecting the future: the regenerative medicine evolutionArticles

Regenerative medicine has left the realms of sci-fi to become a practical, new form of technology, which can give patients amazing results with serious, previously untreatable injuries. However, the legalities...

Read more

News

Roche heads doctor, hospital payment league in 2014

7th July 2015

 Roche heads doctor, hospital payment league in 2014News

The first full year of data collated by the US government on pharma company payments to doctors and hospitals reveals that Roche was the biggest spender in 2014, splashing out...

Read more

Novartis and Juno settle CAR-T patent dispute

7th April 2015

 Novartis and Juno settle CAR-T patent disputeNews

Novartis and Juno Therapeutics have settled a patent dispute centring on CAR-T therapies - one of the most anticipated research areas in the hot topic of cancer immunotherapy.The agreement gives...

Read more

Amgen fails to block Neupogen biosimilar

20th March 2015

 Amgen fails to block Neupogen biosimilarNews

Amgen has failed in a legal attempt to block the sale of a biosimilar version of its white blood cell stimulator Neupogen developed by Novartis' Sandoz subsidiary.The biosimilar – called...

Read more

Tough times ahead in US market for Glaxo and AZ

17th February 2015

 Tough times ahead in US market for Glaxo and AZNews

GlaxoSmithKline has replaced the head of its North American business unit as it struggles to maintain sales in its biggest market.Meanwhile, AstraZeneca has also been dealt a major blow to its...

Read more

Events

Orphan Drugs Summit

17th September 2015 - 18th September 2015

Orphan Drugs Summit

Changing times ask for solid relationships. Times are changing. A renewed interest from big pharma in the rare disease landscape has awakened due to large-scale patent expirations, competition from generics &...

Read more

Biosimilars and Biobetters

30th September 2015

Biosimilars and Biobetters

SMi’s 6th annual Biosimilars and Biobetters conference will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance through technical...

Read more

BRICS Biosimilars Approval Pathways

30th September 2015

BRICS Biosimilars Approval Pathways

Join our online conference and hear how Pharma businesses can collaborate with patient groups and communities to foster research, development and market access for orphan drugs in. Our expert speakers...

Read more

Anti-Counterfeiting and Brand Safety World Summit 2015

1st October 2015 - 2nd October 2015

Anti-Counterfeiting and Brand Safety World Summit 2015

Counterfeit drugs pose a huge threat to the public health worldwide. They are also great challenge for the pharmaceutical industries. The WHO International Medical Products Anti-Counterfeiting Taskforce (IMPACT) estimates that...

Read more